BCYC FY 2020 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-24.7% YoY

Gross Profit

-$23M-219.0% margin

Operating Income

-$52M-500.1% margin

Net Income

-$51M-491.0% margin

EPS (Diluted)

$-2.66

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$161M

Total Liabilities

$66M

Stockholders' Equity

$95M

Cash & Equivalents

$136M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$14M	-24.7%
Gross Profit	-$23M	-$12M	-93.9%
Operating Income	-$52M	-$26M	-97.6%
Net Income	-$51M	-$31M	-66.7%